LifeArc Becomes Technology Transfer Partner to London School of Hygiene & Tropical Medicine
News Jul 26, 2017
LifeArc, the medical research charity previously known as MRC Technology, has signed an agreement with the London School of Hygiene & Tropical Medicine to provide a range of technology transfer services.
LifeArc has expertise in protecting and managing intellectual property, evaluating the translational potential of research portfolios and advising on funding and development pathways. The charity has over 25 years’ experience of providing technology transfer support to a range of organisations, including the Medical Research Council and various charities and non-profit organisations. The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health, with staff working in over 100 countries to improve health worldwide.
“LifeArc exists to make a difference for patients and to achieve this we have to make sure that promising medical research is progressed. The London School of Hygiene & Tropical Medicine shares our aim of addressing major public and global health challenges, and we look forward to providing the expertise to help them maximise their research portfolio,” said Andrew Farquharson, Executive Director, Technology Transfer at LifeArc.
Professor Peter Piot, Director of the London School of Hygiene & Tropical Medicine, said: “The world is facing unprecedented challenges in the form of infectious and chronic conditions, and emerging health threats. We need to innovate to meet these challenges and improve health for all. This exciting partnership with LifeArc will intensify efforts to translate our research in ways that have a tangible impact.”.
Gene Regulator May Contribute to Protein Pileup in Exfoliation GlaucomaNews
Researchers are seeking factors that contribute to protein pileup in exfoliation glaucomaREAD MORE
T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's diseaseNews
Researchers in Germany discover a potential new target for treating Parkinson's diseaseREAD MORE
Working Together Helps Phage Overcome CRISPRNews
Surprising results show that phage join forces to overcome bacteria’s CRISPR -based immune defenses. Improved understanding of the interactions between phage and their bacterial hosts could help advance phage-based therapies and stimulate viral research.READ MORE